Indefinite Delivery Contract SPE2DX15D9902

This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $499,999,999 contract, valid through November 2026, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The contract does not have a set-aside designation, enabling DMS Pharmaceutical Group to leverage its status as a woman-owned small business to supply critical medications and specialized drugs directly to Department of Defense (DoD) and U.S. Department of Veterans Affairs (VA) healthcare facilities nationwide. The delivery orders issued under this IDC cover a diverse array of pharmaceutical products, such as injections, tablets, creams, auto-injectors, and specialty medications, to support the recurring medical supply needs of military personnel and their dependents.

The sample task orders provided indicate that DMS Pharmaceutical Group has been awarded multiple firm fixed-price delivery orders for items like meloxicam tablets, fentanyl citrate injections, midazolam hydrochloride, fluticasone propionate, epinephrine injections, and other essential pharmaceuticals. These delivery orders, ranging in value from a few dollars to over $1,000, are placed by the DLA's Medical Supply Chain under the SPE2DX program to ensure the availability of critical medications for DoD and VA healthcare facilities.